{"id":80827,"date":"2022-01-18T10:20:04","date_gmt":"2022-01-18T15:20:04","guid":{"rendered":"https:\/\/tobaccoreporter.com\/?p=80827"},"modified":"2022-01-18T10:20:04","modified_gmt":"2022-01-18T15:20:04","slug":"22nd-century-to-launch-vln-cigarettes","status":"publish","type":"post","link":"https:\/\/tobaccoreporter.com\/2022\/01\/18\/22nd-century-to-launch-vln-cigarettes\/","title":{"rendered":"22nd Century to Launch VLN Cigarettes in U.S."},"content":{"rendered":"\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t
Photo: 22nd Century<\/figcaption>\n\t\t\t\t\t\t\t\t\t\t<\/figure>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

22nd Century Group plans to launch its VLN reduced-nicotine cigarettes in a major U.S. metropolitan market by March 2022. The debut will be followed by a nationwide launch.<\/p>

On Dec. 23, 2021, the U.S. Food and Drug Administration authorized<\/a> 22nd Century Group\u2019s VLN King and VLN Menthol King as the first reduced-nicotine content cigarettes under the agency\u2019s modified-risk tobacco product designation. Scientific studies show the company\u2019s VLN reduced-nicotine content cigarettes \u201chelp you smoke less.\u201d \u00a0<\/p>

\u201cThe FDA\u2019s MRTP authorization of VLN ushered in a new reality\u2014a combustible cigarette carrying an authorized harm reduction claim supported by extensive scientific and clinical studies, most of which were funded by federal health agencies,\u201d said James A. Mish, CEO of 22nd Century, in a statement<\/a>.<\/p>

\u201cVLN is the only reduced harm product of its kind, and we are confident based on the research that it can absolutely be successful on its own or in combination with other harm reduction products. With an estimated 1,300 deaths per day associated with U.S. smoking, our products that can help people smoke less offer a truly game-changing prospect for millions of American adults who currently smoke.\u201d\u00a0\u00a0<\/p>

During the pilot phase, 22nd Century Group will test and optimize its marketing mix. The pilot will help the company better understand how adult smokers will use this product prior to advancing to national distribution, providing an unmatched tool for helping adult smokers find an off-ramp from nicotine addiction.<\/p>

\u201c22nd Century has secured a well-known national retail partner for VLN\u2019s pilot market launch phase,\u201d said Mish. \u201cWe intend to deploy and test a wide array of marketing materials aimed at adult smokers looking for ways to help them smoke less. These will include marketing at the point of sale, direct materials sent to self-identified adult smokers interested in VLN and online resources, such as our new product site at tryvln.com<\/em>.\u201d<\/p>

While 22nd Century owns or controls the intellectual property that makes VLN tobacco possible, the company has reiterated its willingness and expectation to license the technology to strategic partners.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"

Following a pilot in March, the company will roll out its low-nicotine cigarettes nationwide. <\/p>\n","protected":false},"author":2,"featured_media":80028,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"om_disable_all_campaigns":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[17],"tags":[99],"class_list":["post-80827","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-top-news","tag-22nd-century-group"],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/tobaccoreporter.com\/wp-json\/wp\/v2\/posts\/80827","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/tobaccoreporter.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/tobaccoreporter.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/tobaccoreporter.com\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/tobaccoreporter.com\/wp-json\/wp\/v2\/comments?post=80827"}],"version-history":[{"count":0,"href":"https:\/\/tobaccoreporter.com\/wp-json\/wp\/v2\/posts\/80827\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/tobaccoreporter.com\/wp-json\/wp\/v2\/media\/80028"}],"wp:attachment":[{"href":"https:\/\/tobaccoreporter.com\/wp-json\/wp\/v2\/media?parent=80827"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/tobaccoreporter.com\/wp-json\/wp\/v2\/categories?post=80827"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/tobaccoreporter.com\/wp-json\/wp\/v2\/tags?post=80827"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}